The Icelandic AβPP mutation A673T, also known as Aβ mutation A3T since it occurs within Aβ, was shown to protect its carriers from AD by augmenting the efficiency of BACE1-mediated cleavage at the β’ site within Aβ [1,2]. Here, APP is linked to Alzheimer disease.